ArticleViruses2023

Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits.

Mayanka Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.